Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation
Journal of Extracellular Vesicles · 2024
DOI: 10.1002/jev2.12449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Joël E J Beaumont und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, AMP-Activated Protein Kinases, Glycolysis, Extracellular Vesicles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Zeldzame Ziekten Fonds, ZonMw, KWF Kankerbestrijding.
Abstract (Originalsprache)
Hypoxia is a common feature of solid tumours and activates adaptation mechanisms in cancer cells that induce therapy resistance and has profound effects on cellular metabolism. As such, hypoxia is an important contributor to cancer progression and is associated with a poor prognosis. Metabolic alterations in cells within the tumour microenvironment support tumour growth via, amongst others, the suppression of immune reactions and the induction of angiogenesis. Recently, extracellular vesicles (EV) have emerged as important mediators of intercellular communication in support of cancer progression. Previously, we demonstrated the pro‐angiogenic properties of hypoxic cancer cell derived EV. In this study, we investigate how (hypoxic) cancer cell derived EV mediate their effects. We demonstrate that cancer derived EV regulate cellular metabolism and protein synthesis in acceptor cells through increased activation of mTOR and AMPKα. Using metabolic tracer experiments, we demonstrate that EV stimulate glucose uptake in endothelial cells to fuel amino acid synthesis and stimulate amino acid uptake to increase protein synthesis. Despite alterations in cargo, we show that the effect of cancer derived EV on recipient cells is primarily determined by the EV producing cancer cell type rather than its oxygenation status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
- Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, the Netherlands.
- Department of Cardio & Organ Systems (COS), Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
- Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
- Leuven Cancer Institute (LKI), Leuven, Belgium.
ORCID-Profile: Joël E J Beaumont
Förderung
- Stichting Zeldzame Ziekten Fonds
- ZonMw
- KWF Kankerbestrijding
Zitieren
APA
Beaumont, J. E. J., Barbeau, L. M. O., Ju, J., Savelkouls, K. G., Bouwman, F. G., Zonneveld, M. I., Bronckaers, A., Kampen, K. R., Keulers, T. G. H., & Rouschop, K. M. A. (2024). Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12449
Vancouver
Beaumont JEJ, Barbeau LMO, Ju J, Savelkouls KG, Bouwman FG, Zonneveld MI, et al. Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12449
BibTeX
@article{Beaumont2024,
author = {Beaumont, Joël E J and Barbeau, Lydie M O and Ju, Jinzhe and Savelkouls, Kim G and Bouwman, Freek G and Zonneveld, Marijke I and Bronckaers, Annelies and Kampen, Kim R and Keulers, Tom G H and Rouschop, Kasper M A},
title = {Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation},
journal = {Journal of Extracellular Vesicles},
year = {2024},
doi = {10.1002/jev2.12449}
}
EUVIMED